Pathophysiology of high blood pressure

Reading File
Finding Sources
Finding Sources
Searching PubMed

"hypertension"[MeSH Terms] AND "pathophysiology"[MeSH Terms]

Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive textbook content. Let me compose the full answer.

Pathophysiology of High Blood Pressure (Hypertension)

Hypertension is defined as a sustained elevation in blood pressure (BP) above 130/80 mmHg (ACC/AHA 2017 guidelines) or 140/90 mmHg (older/WHO definition). Over 90% of cases are primary (essential) hypertension, where no single reversible cause is identified. The remaining ~10% are secondary hypertension (renal artery stenosis, primary aldosteronism, pheochromocytoma, etc.).

1. The Fundamental Formula

BP = Cardiac Output (CO) × Total Peripheral Resistance (TPR)
Long-term BP regulation requires more than just this formula. It also depends on:
  • Kidney regulation of body fluid and sodium balance
  • Local autoregulation of tissue blood flow
  • Time-dependent interactions between multiple control systems
In most patients with established primary hypertension, CO is normal and TPR is elevated - not as a primary driver, but as an autoregulatory response to maintain normal tissue perfusion at higher pressures.
  • Fuster and Hurst's The Heart, 15th Ed.

2. Renal Mechanisms and Pressure Natriuresis

The kidney is the most important long-term regulator of BP. It does this via pressure natriuresis: a rise in mean arterial pressure (MAP) of as little as 1-3 mmHg causes the kidney to increase sodium and water excretion, reducing blood volume and returning BP toward normal.

How it works:

  • Rising renal perfusion pressure increases medullary blood flow (less tightly autoregulated than cortical flow), which washes out medullary interstitial NaCl, reducing the osmotic gradient for tubular water reabsorption
  • Elevated pressure reduces proximal tubular reabsorption by altering peritubular capillary Starling forces (lower oncotic pressure, higher hydrostatic pressure)

How it breaks down in hypertension:

  • In essential hypertension, the pressure-natriuresis curve is shifted rightward - the kidney requires a higher BP set-point to excrete a given sodium load
  • This shift can result from: increased renal sympathetic activity, excess angiotensin II, structural nephron loss, reduced nitric oxide generation, or oxidative stress
  • Salt sensitivity (BP rises with sodium intake) is present in ~30% of normotensives and ~60% of hypertensives, and is especially prevalent in Black individuals, the elderly, and those with chronic kidney disease (CKD)
  • National Kidney Foundation Primer on Kidney Diseases, 8e

3. The Renin-Angiotensin-Aldosterone System (RAAS)

The RAAS is a central pressor pathway:
  1. Decreased renal perfusion or sodium delivery → juxtaglomerular cells secrete renin
  2. Renin cleaves angiotensinogen → Angiotensin I
  3. ACE converts Ang I → Angiotensin II (Ang II)
  4. Ang II acts on:
    • Vascular smooth muscle (AT1 receptors): potent vasoconstriction → raises TPR
    • Adrenal cortex: stimulates aldosterone secretion → sodium and water retention → raises CO
    • Renal tubules: directly promotes sodium reabsorption
    • SNS: facilitates norepinephrine release, amplifying sympathetic tone
    • CNS: stimulates thirst and ADH release
In primary hypertension, renin levels are variable (low, normal, or high), meaning RAAS overactivation is not universal, but it remains a key amplifier of hypertension, especially when volume expansion is already present.

4. Sympathetic Nervous System (SNS) Activation

Increased sympathetic activity contributes to hypertension via:
  • Cardiac: increased heart rate and contractility → raises CO
  • Vascular: alpha-1 receptor-mediated vasoconstriction → raises TPR
  • Renal: enhanced tubular NaCl reabsorption + increased renin release from juxtaglomerular apparatus → sodium retention
Obesity is a key driver of SNS activation: adipose tissue increases leptin, which directly stimulates central sympathetic outflow. This explains why overweight and obesity account for 65-75% of the risk for primary hypertension.
  • Fuster and Hurst's The Heart, 15th Ed.

5. Vascular Mechanisms

Endothelial Dysfunction

  • Normal endothelium produces nitric oxide (NO) via nitric oxide synthase (NOS), which causes vasodilation and inhibits tubular NaCl reabsorption
  • In hypertension, NOS activity is reduced, causing impaired vasodilation and increased peripheral resistance
  • Reactive oxygen species (ROS) - especially superoxide (O₂⁻) - inactivate NO by forming peroxynitrite (ONOO⁻), further reducing vasodilatory capacity and promoting oxidative vascular injury

Vascular Remodeling

  • Chronic elevated BP triggers hypertrophic remodeling of vessel walls: smooth muscle hypertrophy, increased wall-to-lumen ratio
  • Capillary rarefaction (reduced capillary density) occurs in tissues, raising TPR structurally
  • The autoregulatory curve shifts rightward in chronic hypertension, meaning lower BPs are now required to maintain adequate perfusion - rapid BP lowering can cause ischemia

Endothelin

  • Produced by vascular endothelium and collecting tubules
  • ET-A receptors mediate vasoconstriction; ET-B receptors promote NO release and natriuresis
  • ET-A overactivation contributes to increased SVR, especially in volume-expanded and CKD-related hypertension
  • National Kidney Foundation Primer on Kidney Diseases, 8e; Fuster and Hurst's The Heart, 15th Ed.

6. Blood Flow Autoregulation in Hypertension

The body regulates tissue blood flow acutely (seconds-minutes) via:
  • Myogenic response: vessels constrict when stretched by high pressure
  • Metabolic response: vasodilation in response to local hypoxia/CO₂ accumulation
In hypertension, this autoregulatory range shifts to higher pressures (see figure below). This protects organs from overperfusion short-term but means BP must be lowered gradually with antihypertensive therapy to avoid ischemia.
Autoregulation of blood flow in hypertension vs normal
Rightward shift of the autoregulation curve in chronic hypertension (red) vs normal (blue). Fuster & Hurst's The Heart, 15th Ed.

7. Hormonal & Humoral Modulators

FactorEffect on BPMechanism
AldosteroneRaisesSodium retention via ENaC in collecting duct
ANP (Atrial Natriuretic Peptide)LowersIncreases GFR, inhibits renin, promotes natriuresis
Endothelin-1Raises (ET-A)Vasoconstriction, sodium retention
Nitric OxideLowersVasodilation, natriuresis
Prostaglandins (PGI₂)LowersVasodilation
Thromboxane A₂RaisesVasoconstriction, platelet aggregation
Reactive Oxygen SpeciesRaisesInactivate NO, promote vasoconstriction
NSAIDs (COX inhibition)RaisesBlock vasodilatory prostaglandins → sodium retention
  • National Kidney Foundation Primer on Kidney Diseases, 8e

8. Obesity-Hypertension Nexus

Obesity causes hypertension through multiple parallel pathways:
  1. Renal compression by perirenal fat → impaired pressure natriuresis
  2. SNS activation via leptin hypersecretion
  3. RAAS activation (adipose tissue expresses local renin-angiotensin components)
  4. Insulin resistance/hyperinsulinemia → promotes tubular sodium reabsorption and SNS activity
  5. Obstructive sleep apnea (common in obesity) → intermittent hypoxia → SNS surges → sustained daytime hypertension

9. Genetic Causes (Secondary/Monogenic)

Rare but well-characterized Mendelian causes illustrate the importance of sodium handling:
DisorderMechanismKey Features
Liddle SyndromeGain-of-function ENaC mutationLow aldosterone, low K⁺, responds to amiloride
Gordon SyndromeExcess NaCl reabsorption (WNK kinase mutations)High K⁺, responds to thiazides
Glucocorticoid-remediable aldosteronism (FH-I)Aldosterone under ACTH controlHigh aldosterone, responds to dexamethasone
AME (Apparent Mineralocorticoid Excess)11β-HSD2 deficiency; cortisol acts on MRLow aldosterone, low K⁺
  • Fuster and Hurst's The Heart, 15th Ed.

10. Hypertension in CKD (Vicious Cycle)

CKD creates a self-reinforcing cycle:
  • Nephron loss → reduced natriuretic capacity → salt sensitivity and volume expansion
  • Volume expansion → higher BP → further glomerular hypertension and injury
  • Injured glomeruli → additional nephron loss → worsening hypertension
  • CKD also: increases endothelin, reduces NO (via ADMA accumulation), amplifies SNS discharge via abnormal afferent renal nerve signals, and promotes oxidative stress

Summary: Integrated Pathophysiology

Genetic predisposition + environmental factors (obesity, excess salt, sedentary lifestyle)
        ↓
Impaired pressure-natriuresis (kidney set-point shifted rightward)
        ↓
Sodium and water retention → ↑ blood volume → ↑ CO
        ↓                              
↑ Ang II, SNS activation, endothelin
        ↓
Vasoconstriction + vascular remodeling → ↑ TPR
        ↓
Endothelial dysfunction (↓ NO, ↑ ROS) → further ↑ TPR
        ↓
SUSTAINED HYPERTENSION
        ↓
Target-organ damage: LVH, nephrosclerosis, atherosclerosis, stroke
The kidney sits at the center of long-term BP control - ultimately, sustained hypertension requires a defect in renal sodium excretion, whether primary (essential) or secondary (CKD, RAAS excess, structural renal disease).
This is a shared conversation. Sign in to Orris to start your own chat.